A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study
Clinical trial NCT05211947 · TERMINATED
Trial details
- NCT number
- NCT05211947
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-21
- Primary completion
- 2025-02-26
- Enrollment
- 1356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.